AdBlock rilevato
We have detected an active AdBlocker!

Please disable your AdBlocker or add this site to your exceptions.

Our advertising is not intrusive and will not disturb you.
It allows the site to sustain itself, grow, and provide you with new content.

You will not be able to access the content as long as AdBlocker remains active.
After disabling it, this window will close automatically.

Sfondo Header
L'angolo del dottorino
Search the site... Advanced search

PERICARDIUM AND PERICARDITIS
(serous, fibrinous, purulent, suppurative, caseous, and hemorrhagic)

The pericardium is a serous membrane that envelops the heart, providing mechanical protection, reducing friction during cardiac movement, and contributing to the maintenance of intrathoracic pressure. It consists of two layers:

Between these two layers there is a virtual space, known as the pericardial cavity, containing a small amount of serous fluid (about 10-50 mL) with lubricating function, produced by pericardial capillaries and reabsorbed by lymphatic vessels.


Pathophysiology of Pericarditis

Pericarditis is an inflammatory process of the pericardium accompanied by a series of structural and functional alterations of the pericardial membrane. Inflammation leads to:


Pericarditis and Pericardial Effusion

Pericarditis is not always associated with a significant effusion: small amounts of fluid may also be present in healthy individuals or in patients with systemic conditions (heart failure, nephrotic syndrome).

When present, the effusion may vary in quantity and composition, influencing the clinical presentation:


Classification of Pericarditis

Pericarditis is classified according to the characteristics of the exudate:

This classification has important clinical implications, as the different forms may have different etiologies, course, and prognosis.


Clinical Presentation and Symptoms

The clinical manifestations of pericarditis may vary according to the severity of inflammation and the amount of pericardial fluid accumulated. The most common symptoms include:


Diagnosis of Pericarditis

Diagnosis is based on a combination of clinical, laboratory, and instrumental data:


Treatment of Pericarditis

Treatment varies according to the cause and severity of pericarditis:


Prognosis and Evolution

The prognosis of pericarditis depends on the underlying cause:

An adequate echocardiographic follow-up is essential to monitor the resolution of inflammation and prevent complications.

Serous Pericarditis

Serous pericarditis is the mildest and most frequently self-limiting form of pericardial inflammation. It is characterized by the presence of a clear exudate or slightly cloudy, rich in proteins, monocytes, and lymphocytes, but devoid of fibrin. This distinction is crucial, as it prevents the formation of adhesions between the pericardial layers.

The inflammatory process is mediated by the production of pro-inflammatory cytokines (IL-1, IL-6, TNF-α), which increase capillary permeability and promote the passage of fluid into the pericardial cavity. However, in the absence of fibrin, resolution is generally spontaneous and without fibrotic sequelae.

Specific Causes

The main causes of serous pericarditis include:

Evolution and Prognosis

Serous pericarditis has a favorable prognosis, with spontaneous resolution in most cases.

In some patients, however, it may evolve into:

Treatment is generally symptomatic with NSAIDs and colchicine. In more complex cases, corticosteroids may be necessary.

Serofibrinous Pericarditis

Serofibrinous pericarditis represents an intermediate form between serous pericarditis and fibrinous pericarditis. It is distinguished by the presence of a cloudy exudate, rich in inflammatory proteins and fibrin strands, which may deposit on the pericardial surfaces.

This condition is associated with a more marked inflammatory process, with greater activation of mediators such as IL-1, IL-6, and TNF-α, which increase vascular permeability and promote the recruitment of inflammatory cells.


Distinctive Features


Main Causes

The causes of serofibrinous pericarditis partially overlap those of the serous form, but with a more intense and prolonged inflammation. Among the main ones:


Evolution and Prognosis

Serofibrinous pericarditis may evolve into:


Treatment involves NSAIDs and colchicine, with possible use of corticosteroids in forms secondary to autoimmune diseases.

Fibrinous Pericarditis

Fibrinous pericarditis represents an advanced stage of serofibrinous pericarditis, characterized by a pericardial exudate almost exclusively fibrinous, with a scant liquid component. The reduced lubrication between the pericardial layers leads to the typical pericardial friction rub, a distinctive clinical sign of this condition.


Distinctive Features


Main Causes

The causes of fibrinous pericarditis include:


Evolution and Prognosis

Fibrinous pericarditis may evolve into:

Treatment involves NSAIDs and colchicine, with possible drainage in the presence of associated effusion.

Purulent or Suppurative Pericarditis

Purulent, or suppurative, pericarditis is a severe form of pericardial inflammation caused by bacterial, fungal, or, more rarely, parasitic infections. It is distinguished by the presence of a dense, yellowish exudate rich in pus, with a high infiltration of neutrophils and a high risk of structural complications.


Distinctive Features


Main Causes

Bacterial infections reach the pericardium via:

The most common pathogens include:


Evolution and Prognosis

Purulent pericarditis has an aggressive course and can lead to:


Treatment

Unlike other forms, purulent pericarditis requires:

Early treatment is crucial to prevent irreversible complications.

Caseous Pericarditis

Caseous pericarditis is a rare form of pericardial inflammation, typically associated with tuberculosis and, more rarely, chronic fungal infections such as histoplasmosis. It is characterized by the presence of a granulomatous, dense, white-yellowish exudate, with caseous necrosis and lymphomonocytic infiltrates.


Distinctive Features


Main Causes

Caseous pericarditis is almost always secondary to:


Evolution and Prognosis

Caseous pericarditis has a strong tendency to progress to constrictive pericarditis, due to progressive deposition of fibrotic tissue and calcifications.

Frequent complications include:


Treatment

Management of caseous pericarditis includes:

Early treatment is essential to avoid irreversible damage.

Hemorrhagic Pericarditis

Hemorrhagic pericarditis is a severe form of pericardial inflammation characterized by the presence of an exudate mixed with blood, fibrin, and, in some cases, pus. This condition is often a sign of advanced systemic diseases or neoplastic processes infiltrating the pericardium.


Distinctive Features


Main Causes

The main causes of hemorrhagic pericarditis include:


Evolution and Prognosis

The main complications of hemorrhagic pericarditis are:


Treatment

Management of hemorrhagic pericarditis varies depending on the underlying cause and includes:

The prognosis strongly depends on the underlying disease and the promptness of treatment.


    References
  1. Maisch B et al. Pericardial Diseases: An Update on Diagnosis and Management. Circulation. 2006;113(12):1622-1632.
  2. Imazio M et al. Evaluation and Treatment of Pericarditis: A Systematic Review. JAMA. 2015;314(14):1498-1506.
  3. Adler Y et al. 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. Eur Heart J. 2015;36(42):2921-2964.
  4. Sagristà-Sauleda J et al. Long-Term Follow-Up of Idiopathic Chronic Pericardial Effusion. N Engl J Med. 1999;341(27):2054-2059.
  5. Ristić AD et al. Diagnostic Pericardiocentesis: Safety, Efficacy, and Indications. Heart. 2003;89(7):821-825.
  6. Maisch B, Seferović PM, Ristić AD. Pericardial Disease: Inflammatory Pericardial Syndromes. Lancet. 2004;363(9410):717-727.
  7. Spodick DH. The Normal and Diseased Pericardium: Current Concepts of Pericardial Physiology, Diagnosis, and Treatment. J Am Coll Cardiol. 2003;42(11):2145-2153.
  8. Imazio M et al. Recurrent Pericarditis: Old and New Therapeutic Options. J Cardiovasc Med. 2010;11(7):440-445.
  9. Permanyer-Miralda G. Acute Pericardial Disease: Approach to Diagnosis and Management. Heart. 2004;90(3):252-256.
  10. Lange RA, Hillis LD. Clinical Practice: Acute Pericarditis. N Engl J Med. 2004;351(21):2195-2202.